Canada Markets close in 4 hrs 40 mins

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
20.51+0.43 (+2.14%)
As of 11:11AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 4.13
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 326.27
52 Week Low 36.82
50-Day Moving Average 314.97
200-Day Moving Average 310.96

Share Statistics

Avg Vol (3 month) 346.33k
Avg Vol (10 day) 356.57k
Shares Outstanding 513.12M
Implied Shares Outstanding 6N/A
Float 83.6M
% Held by Insiders 153.95%
% Held by Institutions 18.06%
Shares Short (Oct 13, 2022) 4237.96k
Short Ratio (Oct 13, 2022) 46.76
Short % of Float (Oct 13, 2022) 47.50%
Short % of Shares Outstanding (Oct 13, 2022) 41.86%
Shares Short (prior month Sept 14, 2022) 4257.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.97%
Return on Equity (ttm)-25.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-5.94M
Diluted EPS (ttm)-0.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.19M
Total Cash Per Share (mrq)1.34
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)75.01
Book Value Per Share (mrq)2.19

Cash Flow Statement

Operating Cash Flow (ttm)-5.64M
Levered Free Cash Flow (ttm)-3.45M